Organogenesis Holdings Inc.

Direct answer

Organogenesis Holdings Inc. is publicly traded on NASDAQ under the ticker ORGO.

Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital...

Can you invest in Organogenesis Holdings Inc.?

Yes. Organogenesis Holdings Inc. trades publicly on NASDAQ as ORGO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Organogenesis Holdings Inc.

Detailed equity research is provided by MarketSnap.